24 hour parental access to expert anaphylaxis management advice

24 hour parental access to expert anaphylaxis management advice: a prospective, blinded, pragmatic effectiveness trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN29793562

Enrollment

Registered

2011-08-16

Start date

2011-09-01

Completion date

Unknown

Last updated

2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaphylaxis, food allergy Injury, Occupational Diseases, Poisoning Anaphylactic shock

Interventions

Provision of 24 hour telephone access to expert allergy clinic staff to assist in family decision to use or not use adrenline autoinjectors in the setting of an unanticipated allergic reaction. 50 fa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Parents of newly referred and exisiting patients (up to 16 years) attending Paediatric Allergy Clinic in Cork University Hospital (CUH) 2. Families trained by CUH clinc staff and demonstrating competence in use of adrenaline autoinjectors to treat anaphylaxis

Exclusion criteria

Exclusion criteria: Familes who do not complete satisfactory CUH training in use of adrenaline autoinjectors to treat anaphylaxis

Design outcomes

Primary

Measure	Time frame
The difference/relative change in quality of life between Intervention and Routine care arms, on an intention-to-treat basis at 6 months	—

Secondary

Measure	Time frame
1. Difference in Food Allergy Quality of Life (FAQL) at 1 month post randomisation 2. Incident reports (number of accident & emergency [A&E]/hospital attendances, use of adrenaline auto-injector in an emergency, inappropriate calls to the helpline)	—

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026